Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07062770 · ClinicalTrials.gov registry record · NA

Assessment of Circuit Rebreathing During CPAP Therapy

A NA study of Obstructive Sleep Apnea (OSA), sponsored by Brigham and Women's Hospital.

Recruiting
Registry status
NA
Development phase
13
Enrollment target
1
Study location

NCT07062770 is a NA study of Obstructive Sleep Apnea (OSA) that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 13 participants, below the 591-participant average among 12 other Obstructive Sleep Apnea (OSA) trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07062770, a NA study of Obstructive Sleep Apnea (OSA), is actively recruiting participants, sponsored by Brigham and Women's Hospital.

RECRUITING
Registry status
NA
Development phase
13 participants
Enrollment target
1
Study location

Study Summary

The goal of this research is to better understand how different CPAP mask designs affect airflow and rebreathing of exhaled carbon dioxide (CO₂) during sleep in individuals with obstructive sleep apnea (OSA).

Interventions

  • DEVICE Continuous positive airway pressure (CPAP)
  • OTHER Mask exhaust port flow

Study Locations (1)

Massachusetts

  • Brigham and Women's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2025-05-27
Est. Completion 2025-12-01
Phase NA

Sponsor

Brigham and Women's Hospital

937 total trials

What the Registry Record Tells You About NCT07062770

The ClinicalTrials.gov registry entry for NCT07062770 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 591-participant average among 12 other Obstructive Sleep Apnea (OSA) trials with a reported enrollment target (98% lower). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obstructive Sleep Apnea (OSA) appearing as the primary indexed condition, and to 2 interventions - of which Continuous positive airway pressure (CPAP) is the first listed.

NCT07062770 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT07062770 about?

NCT07062770 is a clinical study titled "Assessment of Circuit Rebreathing During CPAP Therapy". The goal of this research is to better understand how different CPAP mask designs affect airflow and rebreathing of exhaled carbon dioxide (CO₂) during sleep in individuals with obstructive sleep apnea (OSA).

What is the current status of trial NCT07062770?

This trial is currently recruiting. It is a NA study. The enrollment target is 13 participants. The study started on 2025-05-27. Estimated completion is 2025-12-01.

What conditions does trial NCT07062770 study?

This clinical trial studies the following conditions: Obstructive Sleep Apnea (OSA).

What interventions are being tested in trial NCT07062770?

The interventions under investigation include: Continuous positive airway pressure (CPAP) (DEVICE), Mask exhaust port flow (OTHER).

Who is sponsoring clinical trial NCT07062770?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07062770 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obstructive Sleep Apnea (OSA)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.